Resource data sheet
DNA Bank Top
Please review the QC test results indicated by check icon below as well as clone information before placing your order.

c-erbB2 promoter(533)-pGL2-basic (#RDB02839)

Luciferase reportor driven by c-erbB2

Alternative name p533-luc
Clone info. Luciferase reportor driven by c-erbB2. Please refer Fig.2 of Maeda, T., Cancer Gene Ther. 8 (11): 890-896, 2001 for construction.
Comment Cloned fragment: 39699564 to 39700098(NC_000017.11); relatively -414 to +121, where +1 corresponds to 1 nt of NM_004448.3.
Vector backbone pGL2-basic (Plasmid)
Selectable markers Amp^r
Gene/insert name Human c-erbB2/erb-B Genomic DNA
Depositor|Developer Tagawa, Masatoshi |
 
Additional map

Distribution information

Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms
Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ]
MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ]
Please visit Information of Request for Distribution.[link] 
Terms and conditions for distribution In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature designated by the DEPOSITOR is requested (Maeda, T., Cancer Gene Ther. 8 (11): 890-896, 2001).
Additional terms and conditions:
The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation.
提供案内 (日本国内) [open/close]

必要書類
提供依頼書  [依頼書の記入例 ]
提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ]
手続きの概要は、「提供申込みについて[link]」をご覧ください。
MTAに書く使用条件 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する (Maeda, T., Cancer Gene Ther. 8 (11): 890-896, 2001)。
MTAに書く付加的使用条件：
本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。

Catalog # Resource name Availability Shipping form Fee (non-profit org.)
RDB02839 c-erbB2 promoter(533)-pGL2-basic Under QC test. Please contact us. DNA solution

check Please wait for results of QC test to be uploaded. This clone will be sequenced a portion for examination.

How to cite this biological resource

Materials & Methods section:

The c-erbB2 promoter(533)-pGL2-basic was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB02839).

Reference section:

Maeda, T., O-Wang, J., Matsubara, H., Asano, T., Ochiai, T., Sakiyama, S., Tagawa, M., A minimum c-erbB-2 promoter-mediated expression of herpes simplex virus thymidine kinase gene confers selective cytotoxicity of human breast cancer cells to ganciclovir. Cancer Gene Ther. 8 (11): 890-896 (2001). PMID 11773979. [link to RRC of NBRP]

Further references such as user reports and related articles (go to bottom)

QC test results

check Please wait for results of QC test to be uploaded. This clone will be sequenced a portion for examination.

References

Original, user report and related articles

original Maeda, T., A minimum c-erbB-2 promoter-mediated expression of herpes simplex virus thymidine kinase gene confers selective cytotoxicity of human breast cancer cells to ganciclovir. Cancer Gene Ther. 8 (11): 890-896 (2001). PMID 11773979. [link to RRC of NBRP]
user_report Chiu, J.H., Screening to identify commonly used chinese herbs that affect ERBB2 and ESR1 gene expression using the human breast cancer MCF-7 cell line. Evid. Based Complement. Alternat. Med., 965486 (2014). PMID 24987437. [link to RRC of NBRP]
user_report Noomhorm, N., In vitro and in vivo effects of xanthorrhizol on human breast cancer MCF-7 cells treated with tamoxifen. J. Pharmacol. Sci. 125 (4): 375-385 (2014). PMID 25141924. [link to RRC of NBRP]